Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Coeur Commences Drilling at Silver North's Tim Project (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Concordia Healthcare Corp. T.CXR.R

Healthcare Biotechnology


TSX:CXR.R - Post by User

Concordia Healthcare Corp. > Scotia set CXR target price US$75 and rated outperformance
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Comment by Qh1234on Feb 10, 2016 9:12am
66 Views
Post# 24543022

RE:RE:Scotia set CXR target price US$75 and rated outperformance

RE:RE:Scotia set CXR target price US$75 and rated outperformance
123Health wrote:
Qh1234 wrote:
Rating: Sector Outperform Target 1-Yr: US$75.00 ROR 1-Yr: 189.7%

due to IP, cannot post link.


Is this from 10/16/2015 ?????    If you cannot post the link (?) can you confirm the date the Scotia set this target.  Thanks.


the rating was evaluated on Feb 9, 2016
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities